This distinct PTLD microbiome signature presents a potential novel objective Lyme disease diagnostic tool and new avenue for therapeutics.
Distinct Gut Microbiome Signature in Lyme Disease Patients
Lyme Disease Research Highlights
An artificial intelligence and deep learning-based approach can improve the early detection of the Lyme disease rash
Summary This study shows that artificial intelligence (AI) and deep learning (DL) methods can be used to analyze cell phone rash images to more accurately detect and prescreen the erythema […]
Post-Treatment Lyme Disease as a Research Model for Persistent Symptoms in Lyme Disease
Summary The aim of this paper is to review the current literature on the diagnosis, etiology, risk factors, treatments and heterogeneity of patients with persistent symptoms of Lyme disease. The […]
Case Study: Lyme Disease with Erythema Migrans and Seventh Nerve Palsy in an African-American Man
Summary This case study describes an African-American male who was misdiagnosed for 7 weeks despite the patient exhibiting common symptoms and signs of Lyme disease (including EM rash and facial […]
The General Symptom Questionnaire-30 (GSQ-30): A Brief Measure of Multi-System Symptom Burden in Lyme Disease
This study shows that the General Symptom Questionnaire-30 (GSQ-30) is a valid and reliable self-report instrument that clinicians and researchers could use to assess the multi-system symptom burden and response to treatment among patients with acute and post-treatment Lyme disease.
Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease
Summary Reliable blood biomarkers for the early diagnosis of Lyme disease are needed. This study takes a focused approach to analyze serum proteins of Lyme disease patients relative to healthy […]
